Serum lutein is a promising biomarker for type 2 diabetes mellitus and diabetic kidney disease in the elderly.

Pan, Fenghui; Cui, Wenxia; Gao, Lei; Shi, Xiaoting; Yang, Haiyan; Hu, Yun; Li, Man

Pan, Fenghui; Cui, Wenxia; Gao, Lei; Shi, Xiaoting; Yang, Haiyan; Hu, Yun; Li, Man.

Afiliación

Pan F; Department of Geriatrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Cui W; Department of Geriatrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Gao L; Department of Geriatrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Shi X; Department of Geriatrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Yang H; Department of Geriatrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Hu Y; Department of Geriatrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Li M; Department of Geriatrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.

J Clin Lab Anal ; 36(4): e24350, 2022 Apr.

Article en En | MEDLINE | ID: mdl-35293029

Asunto(s)

Diabetes Mellitus Tipo 2; Nefropatías Diabéticas; Anciano; Biomarcadores; Humanos; Luteína; Curva ROC

Palabras clave

biomarker; diabetic kidney disease; lutein; type 2 diabetes mellitus

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas Tipo de estudio: Prognostic_studies Límite: Aged / Humans Idioma: En Revista: J Clin Lab Anal Asunto de la revista: TECNICAS E PROCEDIMENTOS DE LABORATORIO Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google